Anti-Alpha-Gal Antibodies Against Gangliosides: Preliminary Data on a New Autoimmune Target in Alzheimer's Disease Patients. [PDF]
Naso F +7 more
europepmc +1 more source
Gangliosides in the 21st century: therapeutic prospects for the brain and spine. [PDF]
Magistretti PJ +5 more
europepmc +1 more source
Phospholipase D2 acts upstream of PI4P 5-kinases in the response of neurons to extracellular viscosity. [PDF]
Kundu T, Püschel AW.
europepmc +1 more source
ANTI-GM1 ANTIBODIES IN PATIENTS WITH GUILLAIN-BARRE-SYNDROME
Anti-GM1 antibodies were measured in 22 patients with the Guillain-Barre syndrome (GBS) and compared with anti-GM1 antibody activity in patients with other neurological or immunological diseases and in normal subjects.
MARRINK, J +6 more
core
<i>Streptomyces songxianensis</i> sp. nov. SX92<sup>T</sup>: biocontrol of tobacco black shank and modulation of the rhizosphere microbiome. [PDF]
Zhang M +6 more
europepmc +1 more source
Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis. [PDF]
Kell P +14 more
europepmc +1 more source
Engineered Coiled-Coils Convert Cholera Toxin B-Pentamers into Programmable Membrane Fusogens. [PDF]
Dai W +14 more
europepmc +1 more source
Complement-Regulated Nodal Vulnerability in Guillain-Barré Syndrome and CIDP. [PDF]
Yuki N.
europepmc +1 more source
Asymmetric Guillain-Barré Syndrome as a Stroke Mimic. [PDF]
Zhang G, Wang Y, Yuki N.
europepmc +1 more source

